Microbial Genomics: Innovative Targets and Mechanisms
暂无分享,去创建一个
[1] Xuefu You,et al. Recent Advances in Histidine Kinase-Targeted Antimicrobial Agents , 2022, Frontiers in Chemistry.
[2] Christopher M Thomas,et al. High quality genome annotation and expression visualisation of a mupirocin-producing bacterium , 2022, PloS one.
[3] C. Rock,et al. A genome-wide atlas of antibiotic susceptibility targets and pathways to tolerance , 2022, Nature Communications.
[4] J. Rolain,et al. Application and Challenge of 3rd Generation Sequencing for Clinical Bacterial Studies , 2022, International journal of molecular sciences.
[5] N. Nandi,et al. Dynamics of the Catalytic Active Site of Isoleucyl tRNA Synthetase from Staphylococcus aureus bound with Adenylate and Mupirocin. , 2022, The journal of physical chemistry. B.
[6] Ashutosh Kumar Singh,et al. Analysis of Biosynthetic Gene Clusters, Secretory, and Antimicrobial Peptides Reveals Environmental Suitability of Exiguobacterium profundum PHM11 , 2022, Frontiers in Microbiology.
[7] Adrian Mejia-Santana,et al. Union Is Strength: Target-Based and Whole-Cell High-Throughput Screens in Antibacterial Discovery , 2021, Journal of bacteriology.
[8] Agustín M. Pardo,et al. From Genome to Drugs: New Approaches in Antimicrobial Discovery , 2021, Frontiers in Pharmacology.
[9] V. Sintchenko,et al. Microbial Genomics as a Catalyst for Targeted Antivirulence Therapeutics , 2021, Frontiers in Medicine.
[10] K. Yusoff,et al. Membrane Disruption Properties of Essential Oils—A Double-Edged Sword? , 2021 .
[11] R. Brenk,et al. Riboswitches as Drug Targets for Antibiotics , 2021, Antibiotics.
[12] K. Lai,et al. The Missing Piece: Recent Approaches Investigating the Antimicrobial Mode of Action of Essential Oils , 2021, Evolutionary bioinformatics online.
[13] Jonathan M. Monk,et al. Pangenome Analytics Reveal Two-Component Systems as Conserved Targets in ESKAPEE Pathogens , 2020, mSystems.
[14] Naveen Sorout,et al. The Integration of Genome Mining, Comparative Genomics, and Functional Genetics for Biosynthetic Gene Cluster Identification , 2020, Frontiers in Genetics.
[15] Bernhard Y. Renard,et al. Predicting bacterial virulence factors - evaluation of machine learning and negative data strategies , 2020, Briefings Bioinform..
[16] Miguel A. Matilla,et al. Mining for novel antibiotics in the age of antimicrobial resistance , 2020, Microbial biotechnology.
[17] S. Chopra,et al. FabI (enoyl acyl carrier protein reductase) - A potential broad spectrum therapeutic target and its inhibitors. , 2020, European journal of medicinal chemistry.
[18] K. Chakraborty,et al. Moving away from traditional antibiotic treatment: can macrocyclic lactones from marine macroalga-associated heterotroph be the alternatives? , 2020, Applied Microbiology and Biotechnology.
[19] W. Low,et al. Transcriptomic analysis of multi-drug resistant Escherichia coli K-12 strain in response to Lavandula angustifolia essential oil , 2020, 3 Biotech.
[20] L. Weyrich,et al. Palaeomicrobiology: Application of Ancient DNA Sequencing to Better Understand Bacterial Genome Evolution and Adaptation , 2020, Frontiers in Ecology and Evolution.
[21] Qipeng Yuan,et al. Biosynthesis of aromatic polyketides in microorganisms using type II polyketide synthases , 2020, Microbial Cell Factories.
[22] R. Teta,et al. Identification of the Biosynthetic Gene Cluster of Thermoactinoamides and Discovery of New Congeners by Integrated Genome Mining and MS-Based Molecular Networking , 2020, Frontiers in Chemistry.
[23] Hosein Mohimani,et al. Linking genomics and metabolomics to chart specialized metabolic diversity. , 2020, Chemical Society reviews.
[24] E. Mazurkiewicz,et al. Prevention of biofilm formation by quorum quenching , 2020, Applied Microbiology and Biotechnology.
[25] I. Hanski. Metapopulations , 2019, Encyclopedia of Theoretical Ecology.
[26] Christiane Chbib. Impact of the structure-activity relationship of AHL analogues on quorum sensing in Gram-negative bacteria. , 2019, Bioorganic & medicinal chemistry.
[27] G. Soberón-Chávez,et al. The third quorum-sensing system of Pseudomonas aeruginosa: Pseudomonas quinolone signal and the enigmatic PqsE protein. , 2019, Journal of medical microbiology.
[28] C. MacNair,et al. Creative targeting of the Gram‐negative outer membrane in antibiotic discovery , 2019, Annals of the New York Academy of Sciences.
[29] Fabio Polticelli,et al. In silico Selection and Experimental Validation of FDA-Approved Drugs as Anti-quorum Sensing Agents , 2019, Front. Microbiol..
[30] F. Cohen,et al. Potent LpxC Inhibitors with In Vitro Activity against Multidrug-Resistant Pseudomonas aeruginosa , 2019, Antimicrobial Agents and Chemotherapy.
[31] Robert Penchovsky,et al. Riboswitch distribution, structure, and function in bacteria. , 2019, Gene.
[32] S. Lee,et al. antiSMASH 5.0: updates to the secondary metabolite genome mining pipeline , 2019, Nucleic Acids Res..
[33] Suzana M. Ribeiro,et al. Recent Advances in Anti-virulence Therapeutic Strategies With a Focus on Dismantling Bacterial Membrane Microdomains, Toxin Neutralization, Quorum-Sensing Interference and Biofilm Inhibition , 2019, Front. Cell. Infect. Microbiol..
[34] E. Kristiansson,et al. Identification and reconstruction of novel antibiotic resistance genes from metagenomes , 2019, Microbiome.
[35] B. Felden,et al. Future antibacterial strategies: from basic concepts to clinical challenges. , 2019, The Journal of infectious diseases.
[36] P. Visca,et al. Activity and Impact on Resistance Development of Two Antivirulence Fluoropyrimidine Drugs in Pseudomonas aeruginosa , 2019, Front. Cell. Infect. Microbiol..
[37] J. Mecsas,et al. Promises and Challenges of the Type Three Secretion System Injectisome as an Antivirulence Target. , 2019, EcoSal Plus.
[38] Karunakaran A Kalesh,et al. The Quest for Novel Antimicrobial Compounds: Emerging Trends in Research, Development, and Technologies , 2019, Antibiotics.
[39] C. Francklyn,et al. Progress and challenges in aminoacyl-tRNA synthetase-based therapeutics , 2019, The Journal of Biological Chemistry.
[40] Seth M. Cohen,et al. Targeting Metalloenzymes for Therapeutic Intervention. , 2018, Chemical reviews.
[41] V. Sintchenko,et al. Genome-wide analysis of Streptococcus pneumoniae serogroup 19 in the decade after the introduction of pneumococcal conjugate vaccines in Australia , 2018, Scientific Reports.
[42] C. Harwood,et al. Secondary metabolite production and the safety of industrially important members of the Bacillus subtilis group , 2018, FEMS microbiology reviews.
[43] R. Breaker. Riboswitches and Translation Control. , 2018, Cold Spring Harbor perspectives in biology.
[44] H. Yoshikawa,et al. Essentiality and function of WalK/WalR two-component system: the past, present, and future of research* , 2018, Bioscience, biotechnology, and biochemistry.
[45] A. Miyanaga. Structure and function of polyketide biosynthetic enzymes: various strategies for production of structurally diverse polyketides , 2017, Bioscience, biotechnology, and biochemistry.
[46] Mark M. Tanaka,et al. Comparative genomics of Australian and international isolates of Salmonella Typhimurium: correlation of core genome evolution with CRISPR and prophage profiles , 2017, Scientific Reports.
[47] F. Buckner,et al. Development of Methionyl-tRNA Synthetase Inhibitors as Antibiotics for Gram-Positive Bacterial Infections , 2017, Antimicrobial Agents and Chemotherapy.
[48] M. McConnell,et al. Using bacterial genomes and essential genes for the development of new antibiotics , 2017, Biochemical pharmacology.
[49] H. Jafri,et al. New Strategies Targeting Virulence Factors of Staphylococcus aureus and Pseudomonas aeruginosa , 2017, Seminars in Respiratory and Critical Care Medicine.
[50] Michael A. Skinnider,et al. PRISM 3: expanded prediction of natural product chemical structures from microbial genomes , 2017, Nucleic Acids Res..
[51] Kai Blin,et al. antiSMASH 4.0—improvements in chemistry prediction and gene cluster boundary identification , 2017, Nucleic Acids Res..
[52] Anders F. Andersson,et al. Metapopulation theory identifies biogeographical patterns among core and satellite marine bacteria scaling from tens to thousands of kilometers , 2017, Environmental microbiology.
[53] Y. Eguchi,et al. Angucycline antibiotic waldiomycin recognizes common structural motif conserved in bacterial histidine kinases , 2016, The Journal of Antibiotics.
[54] M. Seyedsayamdost,et al. Antibiotic dialogues: induction of silent biosynthetic gene clusters by exogenous small molecules , 2017, FEMS microbiology reviews.
[55] Meetu Gupta,et al. Bacterial Virulence Factors: Secreted for Survival , 2017, Indian Journal of Microbiology.
[56] Christopher P. Zschiedrich,et al. The Rational Design, Synthesis, and Antimicrobial Properties of Thiophene Derivatives That Inhibit Bacterial Histidine Kinases. , 2016, Journal of medicinal chemistry.
[57] Yuemao Shen,et al. Licoflavonol is an inhibitor of the type three secretion system of Salmonella enterica serovar Typhimurium. , 2016, Biochemical and biophysical research communications.
[58] A. Erwin. Antibacterial Drug Discovery Targeting the Lipopolysaccharide Biosynthetic Enzyme LpxC. , 2016, Cold Spring Harbor perspectives in medicine.
[59] R. Epand,et al. Molecular mechanisms of membrane targeting antibiotics. , 2016, Biochimica et biophysica acta.
[60] M. Gelb,et al. 5-Fluoroimidazo[4,5-b]pyridine Is a Privileged Fragment That Conveys Bioavailability to Potent Trypanosomal Methionyl-tRNA Synthetase Inhibitors , 2016, ACS infectious diseases.
[61] J. Kim,et al. Prospects of a new antistaphylococcal drug batumin revealed by molecular docking and analysis of the complete genome sequence of the batumin-producer Pseudomonas batumici UCM B-321. , 2016, International journal of antimicrobial agents.
[62] Y. Eguchi,et al. Study on in vivo effects of bacterial histidine kinase inhibitor, Waldiomycin, in Bacillus subtilis and Staphylococcus aureus. , 2015, The Journal of general and applied microbiology.
[63] T. Hwa,et al. Inflating bacterial cells by increased protein synthesis , 2015, Molecular systems biology.
[64] N. Makridakis,et al. Whole-genome sequencing targets drug-resistant bacterial infections , 2015, Human Genomics.
[65] Mark Goulian,et al. Signal transduction in histidine kinases: insights from new structures. , 2015, Structure.
[66] A. Cambi,et al. Editorial: Membrane domains as new drug targets , 2015, Front. Physiol..
[67] J. Sumida,et al. Inhibition and Reversal of Microbial Attachment by an Antibody with Parasteric Activity against the FimH Adhesin of Uropathogenic E. coli , 2015, PLoS pathogens.
[68] A. Marina,et al. Bacterial histidine kinases as novel antibacterial drug targets. , 2015, ACS chemical biology.
[69] K. Lewis,et al. A new antibiotic kills pathogens without detectable resistance , 2015, Nature.
[70] J. Sangshetti,et al. Peptide deformylase: a new target in antibacterial, antimalarial and anticancer drug discovery. , 2014, Current medicinal chemistry.
[71] M. Achtman,et al. Distinct Genealogies for Plasmids and Chromosome , 2014, PLoS genetics.
[72] M. Kuhn,et al. LpxC Inhibitors as New Antibacterial Agents and Tools for Studying Regulation of Lipid A Biosynthesis in Gram-Negative Pathogens , 2014, mBio.
[73] O. Franco,et al. Insights into novel antimicrobial compounds and antibiotic resistance genes from soil metagenomes , 2014, Front. Microbiol..
[74] O. Franco,et al. The use of versatile plant antimicrobial peptides in agribusiness and human health , 2014, Peptides.
[75] Changji Zheng,et al. Meleagrin, a New FabI Inhibitor from Penicillium chryosogenum with at Least One Additional Mode of Action , 2013, PloS one.
[76] O. Franco,et al. Purification, biochemical characterization and self-assembled structure of a fengycin-like antifungal peptide from Bacillus thuringiensis strain SM1 , 2013, Front. Microbiol..
[77] E. Donkor. Sequencing of Bacterial Genomes: Principles and Insights into Pathogenesis and Development of Antibiotics , 2013, Genes.
[78] A. Karchmer,et al. Is there a future for FabI inhibitors as antibacterial agents , 2013 .
[79] Robert Penchovsky,et al. Riboswitch-based antibacterial drug discovery using high-throughput screening methods , 2013, Expert opinion on drug discovery.
[80] R. Breaker. Riboswitches and the RNA world. , 2012, Cold Spring Harbor perspectives in biology.
[81] L. Garcia,et al. Quorum quenching quandary: resistance to antivirulence compounds , 2011, The ISME Journal.
[82] Pengcheng Lv,et al. Aminoacyl-tRNA synthetase inhibitors as potent antibacterials. , 2012, Current medicinal chemistry.
[83] J. Walker,et al. Mechanisms Decreasing In Vitro Susceptibility to the LpxC Inhibitor CHIR-090 in the Gram-Negative Pathogen Pseudomonas aeruginosa , 2011, Antimicrobial Agents and Chemotherapy.
[84] D. Livermore. Discovery research: the scientific challenge of finding new antibiotics. , 2011, The Journal of antimicrobial chemotherapy.
[85] Y. Tor,et al. Antibiotics that target protein synthesis , 2011, Wiley interdisciplinary reviews. RNA.
[86] Wim G. J. Hol,et al. Selective Inhibitors of Methionyl-tRNA Synthetase Have Potent Activity against Trypanosoma brucei Infection in Mice , 2011, Antimicrobial Agents and Chemotherapy.
[87] V. Sperandio,et al. Anti-virulence strategies to combat bacteria-mediated disease , 2010, Nature Reviews Drug Discovery.
[88] Igor B. Zhulin,et al. The MiST2 database: a comprehensive genomics resource on microbial signal transduction , 2009, Nucleic Acids Res..
[89] A. West,et al. Histidine Kinases in Two-Component Signaling Pathways , 2010 .
[90] A. Delcour,et al. Outer membrane permeability and antibiotic resistance. , 2009, Biochimica et biophysica acta.
[91] A. Cross. What is a virulence factor? , 2008, Critical care.
[92] Pei Zhou,et al. Mechanism and inhibition of LpxC: an essential zinc-dependent deacetylase of bacterial lipid A synthesis. , 2008, Current pharmaceutical biotechnology.
[93] A. Coates,et al. Novel approaches to developing new antibiotics for bacterial infections , 2007, British journal of pharmacology.
[94] Pei Zhou,et al. Structure of the deacetylase LpxC bound to the antibiotic CHIR-090: Time-dependent inhibition and specificity in ligand binding , 2007, Proceedings of the National Academy of Sciences.
[95] C. Raetz,et al. Lipid A modification systems in gram-negative bacteria. , 2007, Annual review of biochemistry.
[96] R. Rappuoli,et al. The pan-genome: towards a knowledge-based discovery of novel targets for vaccines and antibacterials. , 2007, Drug discovery today.
[97] Pei Zhou,et al. Inhibition of lipid A biosynthesis as the primary mechanism of CHIR-090 antibiotic activity in Escherichia coli. , 2007, Biochemistry.
[98] M. Simon,et al. Two-component signaling systems , 2007 .
[99] M. Inouye,et al. The design and development of Tar-EnvZ chimeric receptors. , 2007, Methods in enzymology.
[100] M. Pirrung,et al. Molecular Validation of LpxC as an Antibacterial Drug Target in Pseudomonas aeruginosa , 2006, Antimicrobial Agents and Chemotherapy.
[101] R. Monaghan,et al. Antibacterial drug discovery--then, now and the genomics future. , 2006, Biochemical pharmacology.
[102] J. Rudolph,et al. A slow, tight-binding inhibitor of the zinc-dependent deacetylase LpxC of lipid A biosynthesis with antibiotic activity comparable to ciprofloxacin. , 2005, Biochemistry.
[103] C. Fraser-Liggett,et al. Insights on biology and evolution from microbial genome sequencing. , 2005, Genome research.
[104] D. Chen,et al. Bacterial Peptide deformylase inhibitors: a new class of antibacterial agents. , 2005, Current medicinal chemistry.
[105] C. Glass,et al. A comprehensive classification system for lipids. , 2005, Journal of lipid research.
[106] D. Payne,et al. Finding the gems using genomic discovery: antibacterial drug discovery strategies – the successes and the challenges , 2004 .
[107] S. Amyes,et al. Microbiology and drug resistance mechanisms of fully resistant pathogens. , 2004, Current opinion in microbiology.
[108] P. Sawangwong,et al. Drugs and Cosmetics from the Sea , 2004, Marine Drugs.
[109] J. Hoch,et al. Developing inhibitors to selectively target two-component and phosphorelay signal transduction systems of pathogenic microorganisms. , 2004, Current medicinal chemistry.
[110] K. Ziegelbauer,et al. New Class of Bacterial Phenylalanyl-tRNA Synthetase Inhibitors with High Potency and Broad-Spectrum Activity , 2004, Antimicrobial Agents and Chemotherapy.
[111] J. Pelletier,et al. Inhibitors of protein synthesis identified by a high throughput multiplexed translation screen. , 2004, Nucleic acids research.
[112] Christoph Freiberg,et al. Identification of antibiotic stress-inducible promoters: a systematic approach to novel pathway-specific reporter assays for antibacterial drug discovery. , 2003, Genome research.
[113] David J Payne,et al. Genomic approaches to antibacterial discovery. , 2004, Methods in molecular biology.
[114] H. Nikaido. Molecular Basis of Bacterial Outer Membrane Permeability Revisited , 2003, Microbiology and Molecular Biology Reviews.
[115] Eric Haugen,et al. Comprehensive transposon mutant library of Pseudomonas aeruginosa , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[116] J. Greene,et al. Microbial genetics: Genetic strategies for antibacterial drug discovery , 2003, Nature Reviews Genetics.
[117] Jeffrey E. Barrick,et al. Riboswitches Control Fundamental Biochemical Pathways in Bacillus subtilis and Other Bacteria , 2003, Cell.
[118] S. D. Mills. The role of genomics in antimicrobial discovery. , 2003, The Journal of antimicrobial chemotherapy.
[119] Harald Labischinski,et al. Proteomic Approach to Understanding Antibiotic Action , 2003, Antimicrobial Agents and Chemotherapy.
[120] A. Murchie,et al. The bacterial ribosome, a promising focus for structure-based drug design. , 2002, Current opinion in pharmacology.
[121] Martha S. Head,et al. Discovery of a Novel and Potent Class of FabI-Directed Antibacterial Agents , 2002, Antimicrobial Agents and Chemotherapy.
[122] J. Koehn,et al. N-Alkyl Urea Hydroxamic Acids as a New Class of Peptide Deformylase Inhibitors with Antibacterial Activity , 2002, Antimicrobial Agents and Chemotherapy.
[123] Jizhong Zhou,et al. Microbial Genomics—Challenges and Opportunities: The 9th International Conference on Microbial Genomes , 2002, Journal of bacteriology.
[124] Elliott Bennett-Guerrero,et al. Structure and function of lipopolysaccharides. , 2002, Microbes and infection.
[125] Jonathan A. Mills,et al. An array of target-specific screening strains for antibacterial discovery , 2002, Nature Biotechnology.
[126] A. K. Forrest,et al. Nanomolar inhibitors of Staphylococcus aureus methionyl tRNA synthetase with potent antibacterial activity against gram-positive pathogens. , 2002, Journal of medicinal chemistry.
[127] Nina Salama,et al. Comparison of Genetic Divergence and Fitness between Two Subclones of Helicobacter pylori , 2001, Infection and Immunity.
[128] S Falkow,et al. Helicobacter pylori genetic diversity within the gastric niche of a single human host , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[129] M. Page,et al. Peptide Deformylase as an Antibacterial Drug Target: Target Validation and Resistance Development , 2001, Antimicrobial Agents and Chemotherapy.
[130] D. Rice,et al. Antibiotic Activity and Characterization of BB-3497, a Novel Peptide Deformylase Inhibitor , 2001, Antimicrobial Agents and Chemotherapy.
[131] R. Kay,et al. Eukaryotic signal transduction via histidine-aspartate phosphorelay. , 2000, Journal of cell science.
[132] G. Vovis,et al. Genomics and Antimicrobial Drug Discovery , 1999, Antimicrobial Agents and Chemotherapy.
[133] Manuel Peitsch,et al. A genome-based approach for the identification of essential bacterial genes , 1998, Nature Biotechnology.
[134] D. Lipman,et al. A genomic perspective on protein families. , 1997, Science.
[135] A. Patchett,et al. Antibacterial Agents That Inhibit Lipid A Biosynthesis , 1996, Science.
[136] E. Koonin,et al. A minimal gene set for cellular life derived by comparison of complete bacterial genomes. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[137] S. Kadam. Mechanism-based screens in the discovery of chemotherapeutic antibacterials. , 1994, Biotechnology.
[138] V. Gold. Compendium of chemical terminology , 1987 .